药品注册申请号:077272
申请类型:ANDA (仿制药申请)
申请人:TORRENT PHARMS
申请人全名:TORRENT PHARMACEUTICALS LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 100MG No No AB 2005/12/07 2005/12/07 Discontinued
002 CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG No No AB 2005/12/07 Prescription
003 CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 300MG No No None 2005/12/07 Discontinued
004 CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 400MG No No None 2005/12/07 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
审批日期提交号审批结论提交分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2005/12/07 ORIG-1(原始申请) Approval
>>>补充申请<<<
审批日期提交号审批结论补充类别或审批类型审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2025/01/27 SUPPL-29(补充) Approval Labeling-Container/Carton Labels,Labeling-Package Insert,Labeling STANDARD
2025/01/27 SUPPL-28(补充) Approval Labeling-Medication Guide,Labeling-Package Insert STANDARD
2021/03/23 SUPPL-21(补充) Approval Labeling-Package Insert,Labeling-Medication Guide STANDARD
2021/03/23 SUPPL-17(补充) Approval Labeling-Package Insert STANDARD
2015/01/20 SUPPL-16(补充) Approval Labeling-Package Insert,Labeling-Medication Guide STANDARD
2015/01/20 SUPPL-15(补充) Approval Labeling-Medication Guide,Labeling-Package Insert STANDARD
2014/02/19 SUPPL-13(补充) Approval Labeling-Package Insert STANDARD
2014/02/19 SUPPL-12(补充) Approval Labeling-Package Insert STANDARD
2012/06/19 SUPPL-11(补充) Approval Labeling STANDARD
2012/01/24 SUPPL-8(补充) Approval Labeling-Package Insert,REMS-Proposal,Labeling-Container/Carton Labels,Labeling-Medication Guide
2009/11/18 SUPPL-7(补充) Approval Labeling
2008/02/11 SUPPL-4(补充) Approval Labeling
2007/12/26 SUPPL-3(补充) Approval Labeling
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
>>>活性成分:CARBAMAZEPINE; 剂型/给药途径:TABLET;ORAL; 规格:100MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
077272 001 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 100MG Discontinued No No AB 2005/12/07 TORRENT PHARMS
>>>活性成分:CARBAMAZEPINE; 剂型/给药途径:TABLET;ORAL; 规格:200MG; 治疗等效代码:AB<<<
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
016608 001 NDA TEGRETOL CARBAMAZEPINE TABLET;ORAL 200MG Prescription Yes Yes AB Approved Prior to Jan 1, 1982 NOVARTIS
070541 001 ANDA EPITOL CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 1986/09/17 TEVA
074649 001 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 1996/10/03 TARO
075948 001 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 2002/02/27 APOTEX
077272 002 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 2005/12/07 TORRENT PHARMS
213284 001 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 2022/08/22 UNICHEM
218221 001 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 2024/02/16 BIONPHARMA
216623 001 ANDA CARBAMAZEPINE CARBAMAZEPINE TABLET;ORAL 200MG Prescription No No AB 2025/04/16 ALEMBIC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2025 DrugFuture->U.S. FDA Drugs Database